Cover art for Abortion foes pressure GOP after midterms

Abortion foes pressure GOP after midterms

Anti-abortion groups demand Trump administration halt mail-order abortion pills post-midterms.

By ·

Nov 16, 2026

9 cards · 1m 30s · tap to begin

From · · · 1m 30s

Abortion foes pressure GOP after midterms

Anti-abortion groups demand Trump administration halt mail-order abortion pills post-midterms.

In brief

Anti-abortion groups demand Trump administration halt mail-order abortion pills post-midterms. Anti-abortion groups are pressuring the Trump administration to stop mail-order abortion pills after midterm losses. Originally reported by Mother Jones.

Midterms hurt pro-life groups

Collage featuring Donald Trump, an email from anti-abortion advocacy groups reflecting on the election results, and Mifepristone pills.

Anti-abortion leaders say midterm losses show their movement is in crisis.

“It’s impossible to sugarcoat it”

Dannenfelser blames Republican turnout

Marjorie Dannenfelser claims Republican consultants turned off conservative voters by ignoring abortion as a voting issue.

“Republican turnout was the major problem in this election”

SBA urges FDA to suspend mifepristone rules

Susan B. Anthony Pro Life America wants Republicans to delay Dr. Heidi Overton's FDA confirmation if Trump administration doesn't commit to suspending mail-order abortion pills.

Overton's confirmation faces opposition

Outgoing Louisiana Republican Bill Cassidy says Overton's confirmation is 'almost disqualifying' due to her vaccine policy role.

“almost disqualifying”

SBA demands FDA safety review reforms

Susan B. Anthony Pro Life America wants FDA to commit to reforms in its delayed mifepristone safety review that will finish in 2027.

“serious flaws”

Overton's anti-abortion stance

Dr. Heidi Overton called mifepristone 'dangerous to women' in a 2023 brief for America First Policy Institute.

“dangerous to women”

Texas shifts abortion policies

Texas Democratic governor Nathan Johnson stopped suing out-of-state abortion-pill providers after winning election.

Mifepristone access grows

Around 15,000 patients access mifepristone monthly despite near-total abortion bans in many states.

FDA review delayed until 2027

FDA's mifepristone safety review is delayed until 2027 after being postponed from 2023.

What it means

Anti-abortion groups are pressuring the Trump administration to stop mail-order abortion pills after midterm losses.

Read the original on Mother Jones

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on susan b anthony pro life america and related topics.